COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 851: Articles 8501-8510  | Next

Effectiveness of 2 and 3 mRNA COVID-19 Vaccines Doses against Omicron and Delta-Related Outpatient Illness among Adults, October 2021 - February 2022
Kim, S., Chung, J., Talbot, K., Grijalva, C. G., Wernli, K., Kiniry, E., Martin, E. T., Monto, A., Belongia, E., McLean, H. Q., Gaglani, M., Mamawala, M., Nowalk, M. P., Moehling Geffel, K., Tartof, S., Florea, A., Lee, J. S., Tenforde, M. W., Patel, M., Flannery, B.
10.1101/2022.04.06.22273535 — Posted: 2022-04-10
Implications of red state/blue state differences in COVID-19 death rates
Adams, M.
10.1101/2022.04.08.22273628 — Posted: 2022-04-10
Longitudinal associations between physical activity and other health behaviours during the COVID-19 pandemic: A fixed effects analysis
Mitchell, J. J., Bu, F., Fancourt, D., Steptoe, A., Bone, J. K.
10.1101/2022.04.07.22273555 — Posted: 2022-04-10
Time series cross-correlation between home range and number of infected people during the medium term of COVID-19 Pandemic in a suburban city
KATO, H., Takizawa, A.
10.1101/2022.04.07.22273581 — Posted: 2022-04-10
Effectiveness of convalescent plasma therapy in COVID-19 patients with haematological malignancies
Shibeeb, S., Ajaj, I., Al-Jighefee, H., Abdallah, A.
10.1101/2022.04.06.22273542 — Posted: 2022-04-10
Protocol for mixed-method study by LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the NHS (LOCOMOTION)
Sivan, M., Greenhalgh, T., Darbyshire, J. L., Mir, G., O'Connor, R. J., Dawes, H., Greenwood, D., O'Connor, D., Horton, M., Petrou, S., de Lusignan, S., Curcin, V., Mayer, E., Casson, A., Milne, R., Rayner, C., Smith, N., Parkin, A., Preston, N. J., Delaney, B. C., LOCOMOTION CONSORTIUM
10.1101/2022.04.09.22273655 — Posted: 2022-04-10
THEMIS: A Framework for Cost-Benefit Analysis of COVID-19 Non-Pharmaceutical Interventions
Bertsimas, D., Li, M. L., Soni, S.
10.1101/2022.04.09.22273656 — Posted: 2022-04-10
Therapeutic of four antiviral drugs in treatment of COVID-19: A protocol for systematic review and Network Meta-analysis
Zhang, L., Gu, W., Li, L., Chen, J.
10.1101/2022.04.05.22273473 — Posted: 2022-04-10
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
Bessen, C., Plaza-Sirvent, C., Bhat, J., Marheinecke, C., Urlaub, D., Bonowitz, P., Busse, S., Schumann, S., Vidal Blanco, E., Skaletz-Rorowski, A., Brockmeyer, N., Overheu, O., Reinacher-Schick, A., Faissner, S., Watzl, C., Pfaender, S., Potthoff, A., Schmitz, I.
10.1101/2022.04.08.22273605 — Posted: 2022-04-10
Psychosocial predictors of COVID-19 vaccine uptake among pregnant women: a cross-sectional study in Greece
Galanis, P. A., Vraka, I., Katsiroumpa, A., Konstantakopoulou, O., Siskou, O., Zogaki, E., Kaitelidou, D.
10.1101/2022.04.06.22273526 — Posted: 2022-04-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).